Vaxart, Inc.
OTC: VXRT
- Raised $20 million (2013)
- 24 clinical trials, 1 active
- Research grants: $3.4 million
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Vivani Medical, Inc.
Nasdaq: VANI
- Raised $28 million (2021)
- 12 clinical trials, 2 active
- Research grants: $236,104
Imricor Medical Systems, Inc.
- Raised $613,079 (2019)
- 2 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $1.3 million
Shoulder Innovations, Inc.
NYSE: SI
- Raised $20 million (2025)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
Cerus Corp
Nasdaq: CERS
- 17 clinical trials, 4 active
- FDA-cleared or approved devices
- Research grants: $3.5 million
SPR Therapeutics, Inc.
- Raised $26 million (2024)
- 10 clinical trials, 1 active
- Research grants: $24 million
- Founded 2009
Milestone Scientific Inc.
NYSE: MLSS
- Raised $2.1 million (2026)
- 1 clinical trial
- FDA-cleared or approved devices
Genvec Inc
- Raised $2 million (2010)
- 9 clinical trials
- Research grants: $12 million
Mirum Pharmaceuticals, Inc.
Nasdaq: MIRM
- Raised $68 million (2026)
- 39 clinical trials, 13 active
- Founded 2018
Clearside Biomedical, Inc.
OTC: CLSDQ
- Raised $3.3 million (2019)
- 14 clinical trials
- 1 FDA-registered device site
- Founded 2011
RxSight, Inc.
Nasdaq: RXST
- Raised $50 million (2017)
- 9 clinical trials, 1 active
- FDA-cleared or approved devices
Active Life Scientific, Inc.
- Raised $1 million (2020)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $11 million
Actuated Medical, Inc.
- Raised $150,000 (2012)
- 3 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $70 million
Stereotaxis, Inc.
NYSE: STXS
- Raised $8.5 million (2012)
- 11 clinical trials, 2 active
- FDA-cleared or approved devices
Dxterity Diagnostics Inc
- Raised $106,250 (2021)
- 9 clinical trials
- 1 FDA-registered device site
- Research grants: $1.9 million
Exicure, Inc.
Nasdaq: XCUR
- Raised $22 million (2018)
- 2 clinical trials
- Research grants: $374,876
- Founded 2011
Imperative Care, Inc.
- Raised $100 million (2026)
- 4 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2015
Revbio, Inc.
- Raised $10 million (2025)
- 5 clinical trials, 4 active
- Research grants: $35 million
- Founded 2016
BioNTech SE
Nasdaq: BNTX
- Raised $150 million (2022)
- 103 clinical trials, 51 active
Collegium Pharmaceutical, Inc
Nasdaq: COLL
- Raised $20 million (2018)
- 1 clinical trial
- Research grants: $472,811
Showing 240 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences